Organised by Wenzhou Medical University
Chair(s)
Prof. John Pieper, Chair, FIP Education Chair, FIP, USA & Prof. Xiaokun Li, President of Wenzhou Medical University, China
Introduction:
In an era marked by intensifying global competition in the biopharmaceutical industry, innovative biopharmaceutical research and development (R&D) has emerged as a core driver for propelling industry advancement and elevating medical standards. China is actively pursuing breakthroughs in this domain, dedicating efforts across the entire innovation chain—from fundamental research to clinical translation. We cordially invite you to join this symposium, where we will dissect the current landscape, milestones, and challenges in innovative biopharmaceutical R&D while exploring tailored strategies for cultivating pharmaceutical innovation talent to meet industry demands.
Programme:
| 13:30 – 13:35 | Chair introduction & Welcome speech |
| Prof. Xiaokun Li, President of Wenzhou Medical University, China | |
| Prof John Pieper, Chair, FIP Education Chair, FIP, USA | |
| 13:35 – 13:55 | R&D of innovative biopharmaceuticals and cultivation of pharmaceutical innovation talents in China |
| Prof. Xiaokun Li, President of Wenzhou Medical University, China | |
| 13:55 – 14:10 | Structure based drug design of FGF hormone |
| Prof. Gaozhi Chen, School of Pharmaceutical Science, Wenzhou Medical University, China | |
| 14:10 – 14:20 | Exploring the Development and Challenges of Pharmacist Workforce and Pharmacy Education in China |
| Prof. Dongning Yao, School of Pharmacy, Nanjing Medical University, China | |
| 14:20 – 14:25 | Q&A |
| 14:25 – 14:30 | Closing |
Learning objectives:
1. Understand the key drivers and status of global biopharmaceutical R&D innovation.
2. Examine the successes and challenges of China's biopharmaceutical R&D across the research - to - application chain.
3. Probe into strategies and pathways for training industry - relevant pharmaceutical innovation talents.
Take home messages:
1. Industrial Landscape: Escalating global competition in biopharmaceuticals, where innovative biopharmaceutical R&D has become the core driver of industry advancement.
2. China's Endeavors: Full-chain advancement of innovative biopharmaceutical R&D (basic research to clinical application) to achieve field-level breakthroughs.
3. Symposium Core: Exploring R&D dynamics, milestones, challenges, and industry-aligned strategies for cultivating pharmaceutical innovation talent.
